NEUROGENETICS INC has a total of 11 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and United States. Its main competitors in its focus markets biotechnology, measurement and organic fine chemistry are MTM LAB AG, ALBITAR MAHER and CARIS LIFE SCIENCES LUXEMBOURG HOLDINGS.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 4 | |
#3 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Organic fine chemistry | |
#4 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Analysing materials | |
#3 | Peptides | |
#4 | Combinatorial chemistry | |
#5 | Microorganisms | |
#6 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Velicelebi Gonul | 9 |
#2 | Saunders Aleister J | 4 |
#3 | Becker Kenneth David | 4 |
#4 | Wang Xin | 4 |
#5 | Tanzi Rudolph E | 4 |
#6 | Bertram Lars | 4 |
#7 | Roos Jack | 3 |
#8 | Kounnas Maria | 2 |
#9 | Blacker Deborah Lynne | 2 |
#10 | Wagner Steven | 2 |
Publication | Filing date | Title |
---|---|---|
WO2004018997A2 | Methods and compositions for modulating amyloid beta | |
AU2003265607A1 | Method of modulating and of identifying agents that modulate intracellular calcium | |
US2004067512A1 | Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin | |
AU2002364894A8 | Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin | |
US2003170678A1 | Genetic markers for Alzheimer's disease and methods using the same | |
AU7353700A | Therapies and reagents for increasing stress resistance and life span |